Financial Results
Glaxo Smith Kline (BIOC.CA) Reports 3 Months Consolidated Results
AI Summary
AI-powered disclosure summary — Coming soon 🔜
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Currency : EGP
F/S Consolidated Period : From 01/01/2026 To 31/03/2026
Net Profit : 4,736,899
F/S Consolidated Period : From 01/01/2025 To 31/03/2025
Net Comparative Profit : 59,125,110
Audit Status : Reviewed
Source : Glaxo Smith Kline
The BoD Report (1,489 KB)
ISIN Code : EGS38171C012
Currency : EGP
F/S Consolidated Period : From 01/01/2026 To 31/03/2026
Net Profit : 4,736,899
F/S Consolidated Period : From 01/01/2025 To 31/03/2025
Net Comparative Profit : 59,125,110
Audit Status : Reviewed
Source : Glaxo Smith Kline
The BoD Report (1,489 KB)